Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nicotinic-antipsychotic drug interactions and cognitive function.

Edward D Levin1, Amir H Rezvani

  • 1Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC 27710, USA. edlevin@duke.edu

EXS
|October 6, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Persisting neurobehavioral consequences of gestational exposure to cadmium and benzo[a]pyrene in rats.

Neurotoxicology and teratology·2025
Same author

Pentilludin reduces rat amphetamine and remifentail self-administration with good pharmacologic and toxicologic profiles.

bioRxiv : the preprint server for biology·2025
Same author

Low dose nicotine administration improves attentional performance in rats but is not blocked by nicotinic antagonists.

Pharmacology, biochemistry, and behavior·2025
Same author

Neurotoxicology and public health issues of cannabis and cannabinoids.

Neurotoxicology·2024
Same author

Persisting neurobehavioral consequences of daily or intermittent paternal cannabis administration in F1 and F2 Rats.

Neurotoxicology·2024
Same author

Embryonic exposures to cadmium and PAHs cause long-term and interacting neurobehavioral effects in zebrafish.

Neurotoxicology and teratology·2024

Nicotine and specific nicotinic receptor agonists improve cognitive function, counteracting antipsychotic drug impairments. However, some antipsychotic drugs, particularly those blocking 5HT2 receptors, may reduce nicotine

Area of Science:

  • Neuroscience
  • Pharmacology

Background:

  • Neuronal nicotinic systems are crucial for cognitive functions affected by antipsychotic drugs.
  • Antipsychotic drugs can impair memory and attention, while nicotine may mitigate these effects.
  • Serotonergic actions of antipsychotics might reduce the efficacy of nicotinic co-treatments.

Purpose of the Study:

  • Investigate the role of hippocampal nicotinic receptors in antipsychotic-nicotinic interactions.
  • Determine the efficacy of selective nicotinic agonists in improving cognitive deficits.
  • Explore how antipsychotic drug properties influence nicotinic co-treatment effectiveness.

Main Methods:

  • Administered nicotine and selective nicotinic agonists (alpha7, alpha4beta2) to models of cognitive impairment.
  • Utilized hippocampal infusions of nicotinic antagonists to mimic receptor deficits.

Related Experiment Videos

  • Examined the effects of clozapine, risperidone, and haloperidol on cognitive function and nicotine's effects.

    • Main Results:

    • Selective alpha7 and alpha4beta2 nicotinic agonists significantly enhanced learning and memory.
    • Hippocampal alpha7 and alpha4beta2 receptor suppression impaired spatial working memory.
    • Clozapine's memory deficits were reduced by alpha4beta2 receptor suppression but worsened by alpha7 suppression.
    • 5HT2 receptor antagonism by clozapine and ketanserin attenuated nicotine-induced cognitive improvements.

    Conclusions:

    • Nicotinic co-treatments show promise for managing schizophrenia's cognitive impairment.
    • Targeting alpha7 and alpha4beta2 nicotinic receptors may offer therapeutic benefits.
    • Antipsychotic drugs with 5HT2 receptor blockade may limit the efficacy of nicotinic cognitive enhancement therapies.